相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。A Comprehensive and Comparative Review of Global Gastric Cancer Treatment Guidelines
Sang Soo Eom et al.
JOURNAL OF GASTRIC CANCER (2022)
Japanese gastric cancer treatment guidelines 2018 (5th edition)
GASTRIC CANCER (2021)
A randomized phase III trial comparing adjuvant single-agent S1, S-1 with oxaliplatin, and postoperative chemoradiation with S-1 and oxaliplatin in patients with node-positive gastric cancer after D2 resection: the ARTIST 2 trial
S. H. Park et al.
ANNALS OF ONCOLOGY (2021)
Comparison of Long-Term Efficacy in S-1 and Capecitabine With Oxaliplatin as Adjuvant Chemotherapy for Patients With Gastric Cancer After Curative Surgery: A Retrospective, Single-Center Observational Study
Sung E. Oh et al.
TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2021)
Long-term Efficacy of S-1 Monotherapy or Capecitabine Plus Oxaliplatin as Adjuvant Chemotherapy for Patients with Stage II or III Gastric Cancer after Curative Gastrectomy: a Propensity Score-Matched Multicenter Cohort Study
Chang Min Lee et al.
JOURNAL OF GASTRIC CANCER (2020)
Addition of Docetaxel to Oral Fluoropyrimidine Improves Efficacy in Patients With Stage III Gastric Cancer: Interim Analysis of JACCRO GC-07, a Randomized Controlled Trial
Kazuhiro Yoshida et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Current status of adjuvant chemotherapy for gastric cancer
In-Hwan Kim
WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY (2019)
Efficacy of capecitabine and oxaliplatin versus S-1 as adjuvant chemotherapy in gastric cancer after D2 lymph node dissection according to lymph node ratio and N stage
Kabsoo Shin et al.
BMC CANCER (2019)
Korean Practice Guideline for Gastric Cancer 2018: an Evidence-based, Multi-disciplinary Approach
JOURNAL OF GASTRIC CANCER (2019)
Efficacy of Adjuvant S-1 Versus XELOX Chemotherapy for Patients with Gastric Cancer After D2 Lymph Node Dissection: A Retrospective, Multi-Center Observational Study
In-Hwan Kim et al.
ANNALS OF SURGICAL ONCOLOGY (2018)
Predictive test for chemotherapy response in resectable gastric cancer: a multi-cohort, retrospective analysis
Jae-Ho Cheong et al.
LANCET ONCOLOGY (2018)
Adjuvant Chemoradiotherapy With Epirubicin, Cisplatin, and Fluorouracil Compared With Adjuvant Chemoradiotherapy With Fluorouracil and Leucovorin After Curative Resection of Gastric Cancer: Results From CALGB 80101 (Alliance)
Charles S. Fuchs et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Comparison of capecitabine and oxaliplatin with S-1 as adjuvant chemotherapy in stage III gastric cancer after D2 gastrectomy
Jang Ho Cho et al.
PLOS ONE (2017)
Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
E. C. Smyth et al.
ANNALS OF ONCOLOGY (2016)
Combination or single-agent chemotherapy as adjuvant treatment of gastric cancer A systematic review and meta-analysis of published trials
Roberto Iacovelli et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2016)
Gastric Cancer, Version 3.2016
Jaffer A. Ajani et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2016)
Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial
Yung-Jue Bang et al.
LANCET (2012)
Perioperative Chemotherapy Compared With Surgery Alone for Resectable Gastroesophageal Adenocarcinoma: An FNCLCC and FFCD Multicenter Phase III Trial
Marc Ychou et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial
Ilfet Songun et al.
LANCET ONCOLOGY (2010)
Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine
Shinichi Sakuramoto et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer
David Cunningham et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction.
JS Macdonald et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)